Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial

Affiliations

¹ Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: Felix.20@osu.edu.
² Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
³ Washington University School of Medicine, St. Louis, MO, USA.
⁴ Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC, USA.
⁵ Division of Gynecologic Oncology, The Ohio State University College of Medicine, Columbus, OH, USA.
⁶ NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA.
⁷ Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital/Brown University, Providence, RI, USA.
⁸ Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA.
⁹ Anatomical Pathology, University of Maryland, College Park, MD, USA.
¹⁰ Surgical Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹¹ Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
¹² Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

PMID: 26341710
PMCID: PMC4587355
DOI: 10.1016/j.ygyno.2015.08.022

Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial

Ashley S Felix et al. Gynecol Oncol. 2015 Oct.

. 2015 Oct;139(1):70-6.

doi: 10.1016/j.ygyno.2015.08.022. Epub 2015 Sep 1.

Authors

Affiliations

¹ Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: Felix.20@osu.edu.
² Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
³ Washington University School of Medicine, St. Louis, MO, USA.
⁴ Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC, USA.
⁵ Division of Gynecologic Oncology, The Ohio State University College of Medicine, Columbus, OH, USA.
⁶ NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA.
⁷ Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital/Brown University, Providence, RI, USA.
⁸ Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA.
⁹ Anatomical Pathology, University of Maryland, College Park, MD, USA.
¹⁰ Surgical Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹¹ Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
¹² Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

PMID: 26341710
PMCID: PMC4587355
DOI: 10.1016/j.ygyno.2015.08.022

Abstract

Background: Few studies have analyzed relationships between risk factors for endometrial cancer, especially with regard to aggressive (non-endometrioid) histologic subtypes, and prognosis. We examined these relationships in the prospective NRG Oncology/Gynecologic Oncology Group 210 trial.

Methods: Prior to surgery, participants completed a questionnaire assessing risk factors for gynecologic cancers. Pathology data were derived from clinical reports and central review. We used the Fine and Gray subdistribution hazards model to estimate subhazard ratios (HRs) and 95% confidence intervals (CIs) for associations between etiologic factors and cause-specific subhazards in the presence of competing risks. These models were stratified by tumor subtype and adjusted for stage and socioeconomic status indicators.

Results: Median follow-up was 60months after enrollment (range: 1day-118months). Among 4609 participants, a total of 854 deaths occurred, of which, 582 deaths were attributed to endometrial carcinoma. Among low-grade endometrioid cases, endometrial carcinoma-specific subhazards were significantly associated with age at diagnosis (HR=1.04, 95% CI=1.01-1.06 per year, P-trend) and BMI (class II obesity vs. normal BMI: HR=2.29, 95% CI=1.06-4.98, P-trend=0.01). Among high-grade endometrioid cases, endometrial carcinoma-specific subhazards were associated with age at diagnosis (HR=1.05, 95% CI=1.02-1.07 per year, P-trend<0.001). Among non-endometrioid cases, endometrial carcinoma-specific subhazards were associated with parity relative to nulliparity among serous (HR=0.55, 95% CI=0.36-0.82) and carcinosarcoma cases (HR=2.01, 95% CI=1.00-4.05).

Discussion: Several endometrial carcinoma risk factors are associated with prognosis, which occurs in a tumor-subtype specific context. If confirmed, these results would suggest that factors beyond histopathologic features and stage are related to prognosis. ClinicalTrials.gov Identifier: NCT00340808.

Keywords: Endometrial cancer; Etiologic factors; GOG; NRG; Prognosis.

Published by Elsevier Inc.

PubMed Disclaimer

References

1. Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S105–43. - PubMed
1. Anderson B, Connor JP, Andrews JI, et al. Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol. 1996;174(4):1171–8. discussion 1178–9. - PubMed
1. Studzijnski Z, Zajewski W. Factors affecting the survival of 121 patients treated for endometrial carcinoma at a Polish hospital. Arch Gynecol Obstet. 2003;267(3):145–7. - PubMed
1. Everett E, Tamimi H, Greer B, et al. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol. 2003;90(1):150–7. - PubMed
1. Kodama J, Seki N, Ojima Y, et al. Correlation of presenting symptoms and patient characteristics with endometrial cancer prognosis in Japanese women. Int J Gynaecol Obstet. 2005;91(2):151–6. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial

Affiliations

Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

Associated data

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical